Literature DB >> 30396930

PROX1 Is Associated with Cancer Progression and Prognosis in Gastric Cancer.

Koji Ueta1,2, Yasunori Otowa3,2, Yoshihiro Kakeji2, Masanori Hirashima3.   

Abstract

BACKGROUND: It was recently reported that expression of prospero homeobox protein-1 (PROX1) is correlated with the prognosis of esophageal cancer and colorectal cancer. However, its correlation with gastric cancer is unclear.
MATERIALS AND METHODS: Our study analyzed the effect of PROX1 knockdown on the migration, invasion and proliferation of the MKN45 human gastric cancer cell line. The correlation between PROX1 expression levels and clinicopathological factors were also analyzed in tumor samples from 99 patients with gastric cancer.
RESULTS: Migration, invasion and proliferation were significantly reduced in MKN45 cells with PROX1 knockdown. PROX1 expression was detected in gastric cancer tissues at various levels. PROX1 expression levels were positively correlated with cancer stage, N factor, lymphatic vascular invasion, and vascular invasion in patients with gastric cancer. Analysis of overall and recurrence-free survival indicated that high PROX1 expression was significantly correlated with poor prognosis.
CONCLUSION: PROX1 can be an indicator of poor prognosis and a molecular target for gastric cancer treatment. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  MKN45; PROX1; gastric cancer; poor prognosis

Mesh:

Substances:

Year:  2018        PMID: 30396930     DOI: 10.21873/anticanres.12966

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Circ_0007534 Silencing Inhibits the Proliferation, Migration and Invasion and Induces the Apoptosis of Glioma Cells Partly Through Down-Regulating PROX1 Via Elevating miR-22-3p Level.

Authors:  Yong Zheng; Yan Wang; Rongkang Mai; Liang Liu; Zifeng Zhu; Yiyao Cao
Journal:  Cell Mol Neurobiol       Date:  2021-09-18       Impact factor: 4.231

Review 2.  Update on molecular biomarkers for diagnosis and prediction of prognosis and treatment responses in gastric cancer.

Authors:  Masahiro Sasahara; Mitsuro Kanda; Yasuhiro Kodera
Journal:  Histol Histopathol       Date:  2021-03-09       Impact factor: 2.303

3.  High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1.

Authors:  Aaro Kasurinen; Silvia Gramolelli; Jaana Hagström; Alli Laitinen; Arto Kokkola; Yuichiro Miki; Kaisa Lehti; Masakazu Yashiro; Päivi M Ojala; Camilla Böckelman; Caj Haglund
Journal:  Cancer Med       Date:  2019-09-27       Impact factor: 4.452

4.  LGR5 expression is associated with prognosis in poorly differentiated gastric adenocarcinoma.

Authors:  Takehito Ehara; Takeshi Uehara; Tomoyuki Nakajima; Yasuhiro Kinugawa; Shota Kobayashi; Mai Iwaya; Hiroyoshi Ota; Yuji Soejima
Journal:  BMC Cancer       Date:  2021-03-06       Impact factor: 4.430

5.  miR-301-3p directly regulates Cx43 to mediate the development of gastric cancer.

Authors:  Shasha Liu; Yang Zhao; Huan Liu; Xing Zhao; Xingbin Shen
Journal:  J Int Med Res       Date:  2021-09       Impact factor: 1.671

6.  Lack of relationship between PROX1 expression and clinicopathological parameters and prognosis in gastric cancer patients: a meta-analysis and TCGA analysis.

Authors:  Zirui Jia; Yuhang Wang; Jiacheng Gao; Guo Zu
Journal:  BMC Gastroenterol       Date:  2022-03-27       Impact factor: 3.067

Review 7.  The Role of PROX1 in Neoplasia: A Key Player Often Overlooked.

Authors:  Evangelia Ntikoudi; Alexandros Pergaris; Stylianos Kykalos; Ekaterini Politi; Stamatios Theocharis
Journal:  Diagnostics (Basel)       Date:  2022-07-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.